News | May 31, 2013

IMRT May Not Be More Effective Than Older Radiation Techniques After Prostatectomy

Study evaluates the long-term outcomes of prostate cancer patients who received radiation treatments following prostatectomies.

May 31, 2013 — Intensity-modulated radiation therapy (IMRT) has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, less expensive forms of radiation therapy in patients who have had a prostatectomy.

The comparative effectiveness study, published online by JAMA Internal Medicine, evaluated the long-term outcomes of prostate cancer patients who received radiation treatments following prostatectomies using conformal radiation therapy (CRT) against the newer and more expensive IMRT.

Study lead Ronald Chen, M.D., MPH, assistant professor of radiation oncology in the UNC School of Medicine, said the results showed little difference in the long-term health of patients who used the newer and older radiation therapies.

“Many prostate cancer patients need radiation treatment after prostatectomy, the surgical removal of the prostate, either because the cancer is aggressive or for recurrence. In prostate cancer, we have seen a trend in our healthcare system where new technologies are adopted quickly, maybe because there is a belief that newer treatments are better, but often there is a lack of studies to actually compare patient outcomes from older versus newer treatments,” said Chen.

The study used Medicare data to compare the outcomes of 457 IMRT and 557 CRT patients treated between 2002 and 2007. The patients, 66 years of age or older who underwent radical prostatectomy and subsequent radiation therapy within three years of their surgery, showed no difference in regards to urinary side effects, bowel side effects, sexual dysfunction and other long-term side effects or cancer control.

“For patients with newly diagnosed prostate cancer who have chosen to receive curative radiation treatment, our prior study showed that IMRT was associated with less long-term side effects and better cancer control than CRT. However, for patients who have had a prostatectomy already, and subsequently need radiation treatment, this study shows that IMRT and CRT seemed to have similar outcomes,” said Chen.

A lot of men across the United States who need radiation therapy after prostatectomy are not getting it, according to Chen, and he speculates that the cost of treatment may play a factor. While research shows that as many as one-third to one-half of the patients undergoing surgery for prostate cancer may benefit from radiation treatments subsequently to achieve a cure, Chen said that the data show only 10 to 15 percent of those who could benefit actually receive the therapy.

“If 3-D conformal radiation provides an effective and safe treatment for these patients, then we can probably show that radiation is a very cost effective treatment and potentially remove one of the large obstacles to patients being able to get this necessary treatment after surgery,” said Chen.

For more information: archinte.jamanetwork.com

Related Content

Elekta Expands Mosaiq Oncology Information System With PalabraApps
News | Oncology Information Management Systems (OIMS) | April 20, 2018
April 20, 2018 — Elekta announced that it is making a strategic investment in PalabraApps LLC to advance the developm
This image, taken with Canon's Aquilion One, shows a lung with metastases from bowel cancer.

This image, taken with Canon’s Aquilion One, shows a lung with metastases from bowel cancer. Image courtesy of Canon.

Feature | Lung Cancer | April 18, 2018 | Jeff Zagoudis
In recent years, low-dose computed tomography (CT) screening has emerged as a proven, effective method to detect lung
Chest X-ray AI Algorithm Correctly Identifies Lung Disease for Dubai Health Authority
Feature | Artificial Intelligence | April 17, 2018
The Dubai Health Authority (DHA) announced the preliminary results of a chest X-ray artificial intelligence (AI)...
Varian Launches Velocity 4.0 Cancer Imaging Software
Technology | Treatment Planning | April 16, 2018
April 16, 2018 — Varian announced a new version of its Velocity cancer imaging software that includes Rapidsphere, a
First Patient Treated in Online Adaptive Radiotherapy Trial With CyberKnife System
News | Stereotactic Body Radiation Therapy (SBRT) | April 06, 2018
Accuray Inc. and Erasmus MC announced the first patient has been successfully treated using an online-adaptive (OA)...
First Patient Treated on Mevion's S250i Proton Therapy System
News | Proton Therapy | April 05, 2018
Mevion Medical Systems announced the treatment of the first patient in the world on the Mevion S250i Proton Therapy...
ASTRO Updates Guidelines for Palliative Lung Radiation Therapy
News | Radiation Therapy | April 05, 2018
The American Society for Radiation Oncology (ASTRO) issued an update to its clinical guideline for the use of...
News | Endoscopes | April 02, 2018
Results from a recent prospective trial found the Wide Area Transepithelial Sampling with 3D Tissue Analysis (WATS3D)...
Edwards Completes Enrollment in PARTNER 3 Low-Risk CT Sub-Study
News | Computed Tomography (CT) | March 27, 2018
March 27, 2018 — Edwards Lifesciences Corp.
Combination Radiotherapy Beneficial in Treating Prostate Cancer
News | Prostate Cancer | March 27, 2018
March 27, 2018 — While there are many treatment options for men with...
Overlay Init